 - Subject has received radio-immunotherapy within 6 months prior to 1st dose of study drug; Subject has received an antibody therapy or other biologics with the exception of colony stimulating factors G-CSF,GM-CSF or erythropoietin within 28 days prior to 1st dose of study drug; 